How to Get Vardenafil (Levitra/Staxyn) in Oklahoma

At a glance
- Drug / vardenafil (brand names Levitra, Staxyn), a PDE5 inhibitor for erectile dysfunction
- Prescription required / yes, Schedule non-controlled but prescription-only in Oklahoma
- Telehealth prescribing / legal and active in Oklahoma for vardenafil
- 503A compounding / permitted in Oklahoma with a valid patient-specific prescription
- Oklahoma Medicaid / does not cover vardenafil for erectile dysfunction
- Dosing / 10 mg oral tablet taken 30 to 60 minutes before sexual activity, adjustable to 5 mg or 20 mg
- Prescribers / MDs, DOs, NPs (with prescriptive authority), and PAs can prescribe in Oklahoma
- Generic availability / generic vardenafil widely available since 2018, significantly lower cost than brand Levitra
Vardenafil Prescribing Rules in Oklahoma
Oklahoma follows standard federal requirements for vardenafil: any licensed prescriber with authority to write prescriptions can prescribe it after a clinical evaluation. The state does not impose additional restrictions beyond federal scheduling (vardenafil is not a controlled substance) or require a specialist referral.
Who Can Write the Prescription
MDs and DOs hold full prescriptive authority in Oklahoma. Nurse practitioners gained full practice authority under Oklahoma's APRN legislation after completing a transition-to-practice period, meaning NPs can independently prescribe vardenafil without physician oversight once that period concludes. Physician assistants prescribe under a supervising physician's collaborative agreement, which typically includes PDE5 inhibitors without special carve-outs.
Required Clinical Evaluation
Before prescribing vardenafil, clinicians perform a cardiovascular risk assessment. The 2018 AUA guideline on erectile dysfunction recommends checking blood pressure, heart rate, and a focused cardiac history. PDE5 inhibitors are contraindicated in patients taking nitrates (nitroglycerin, isosorbide) due to the risk of severe hypotension [1]. Most prescribers also review a basic metabolic panel, fasting glucose or HbA1c, and a lipid panel to screen for diabetes and cardiovascular disease, which are the two most common organic causes of ED in men over 40.
Labs Typically Ordered
A total testosterone level is standard if the patient reports low libido alongside erectile difficulty. The Endocrine Society guideline recommends morning total testosterone for men with ED symptoms, with a threshold of 300 ng/dL prompting further workup. A PSA may be added for men over 50. These labs can be drawn at any LabCorp or Quest Diagnostics location in Oklahoma before or after the initial consultation.
Telehealth Access to Vardenafil in Oklahoma
Oklahoma law explicitly permits telehealth prescribing for non-controlled medications, including vardenafil. Patients can complete an evaluation via synchronous video or audio visit with an Oklahoma-licensed prescriber without an initial in-person visit.
How the Process Works
A telehealth consultation for vardenafil in Oklahoma typically takes 10 to 20 minutes. The prescriber reviews medical history, current medications (with particular attention to nitrates, alpha-blockers, and CYP3A4 inhibitors), and cardiovascular status. If vardenafil is appropriate, the prescription is sent electronically to the patient's chosen pharmacy. Most telehealth platforms can deliver a prescription the same day.
Oklahoma-Specific Telehealth Regulations
The Oklahoma Medical Board requires that telehealth prescribers hold an active Oklahoma medical license or a compact license through the Interstate Medical Licensure Compact, which Oklahoma joined. This means out-of-state physicians with compact privileges can legally prescribe vardenafil to Oklahoma residents. NPs must also hold Oklahoma APRN licensure. The prescriber-patient relationship can be established through the telehealth encounter itself [2].
Choosing a Telehealth Provider
When selecting a telehealth platform, verify three things: the prescriber is Oklahoma-licensed, the platform sends prescriptions to Oklahoma pharmacies (including 503A compounding pharmacies if you prefer compounded vardenafil), and the service provides follow-up access for dose adjustments. Vardenafil dosing may need modification based on response and tolerability. The starting dose of 10 mg works for most men, but the Porst et al. Key trial (N=580) demonstrated that the 20 mg dose produced significantly higher rates of successful intercourse (75%) compared to placebo (41%) in men with moderate to severe ED [3].
Pharmacy Options in Oklahoma
Oklahoma has strong pharmacy infrastructure for vardenafil, including chain pharmacies, independent pharmacies, and licensed 503A compounding pharmacies.
Retail and Chain Pharmacies
Generic vardenafil tablets are stocked at CVS, Walgreens, Walmart, and most independent pharmacies across Oklahoma. Cash prices for generic vardenafil 20 mg range from $8 to $35 per tablet depending on the pharmacy and whether discount programs (GoodRx, RxSaver, manufacturer coupons) are applied. Brand-name Levitra, where still available, runs $60 to $70 per tablet without insurance. Staxyn (the orally disintegrating formulation) is less commonly stocked and more expensive.
503A Compounding Pharmacies
Oklahoma licenses 503A compounding pharmacies through the Oklahoma State Board of Pharmacy. These pharmacies can compound vardenafil in custom dosages or alternative forms (sublingual troches, for example) with a valid patient-specific prescription. A 503A pharmacy cannot compound vardenafil "in anticipation of" a prescription without an individual patient order. Several Oklahoma-based compounding pharmacies ship statewide, and out-of-state 503A pharmacies can also ship into Oklahoma if they hold a non-resident pharmacy license from the Oklahoma Board.
Mail-Order and 90-Day Supplies
For patients using vardenafil regularly, mail-order pharmacies offer 90-day supplies at lower per-tablet costs. Express Scripts, Optum Rx, and Amazon Pharmacy all ship to Oklahoma addresses. A 90-day supply of generic vardenafil typically costs 15% to 25% less per dose than filling monthly at a retail pharmacy.
Insurance Coverage and Prior Authorization in Oklahoma
Coverage for vardenafil varies widely depending on the payer. Understanding the prior authorization process saves weeks of delays.
Oklahoma Medicaid (SoonerCare)
Oklahoma Medicaid (SoonerCare) does not cover vardenafil or other PDE5 inhibitors for erectile dysfunction. This exclusion applies to both fee-for-service and managed care plans. Patients covered by SoonerCare must pay cash or use discount programs.
Commercial Insurance
Most commercial plans in Oklahoma (Blue Cross Blue Shield of Oklahoma, CommunityCare, GlobalHealth) include generic vardenafil on formulary, typically at Tier 2 or Tier 3 with prior authorization. A 2019 analysis in the Journal of Sexual Medicine found that 68% of commercial plans required prior authorization for PDE5 inhibitors, with quantity limits of 6 to 12 tablets per month being the most common restriction [4].
Prior Authorization Documentation
When prior authorization is required, Oklahoma insurers typically ask for:
- A documented diagnosis of erectile dysfunction (ICD-10 code N52.9 or subtype)
- Evidence that the prescriber assessed cardiovascular risk
- Confirmation that nitrate therapy is not concurrent
- Trial-and-failure documentation if the insurer requires step therapy (usually with sildenafil first)
The turnaround time for prior authorization in Oklahoma averages 3 to 5 business days. Urgent requests can be processed in 24 hours. If denied, patients have the right to an external review through the Oklahoma Insurance Department.
Medicare Part D
Medicare Part D does not cover vardenafil or any ED medications. This federal exclusion applies regardless of the Part D plan selected. Medicare Advantage plans occasionally offer supplemental ED drug benefits, but this is uncommon in Oklahoma's current plan field.
Transferring a Prescription to Oklahoma
Patients moving to Oklahoma or visiting from another state can transfer an existing vardenafil prescription to an Oklahoma pharmacy.
In-State Transfer Process
Oklahoma follows the standard DEA and state board guidelines for prescription transfers. Since vardenafil is not a controlled substance, the transfer is straightforward. The receiving Oklahoma pharmacy contacts the originating pharmacy, verifies remaining refills, and processes the transfer. This typically takes 1 to 4 hours. E-prescribing transfers are fastest.
Out-of-State Prescriptions
An out-of-state prescription for vardenafil is valid in Oklahoma as long as the prescribing clinician is licensed in the state where the prescription originated. Oklahoma pharmacies accept out-of-state prescriptions for non-controlled medications without additional verification beyond standard practice. If you are relocating permanently, establishing care with an Oklahoma-licensed prescriber ensures uninterrupted refills.
Vardenafil Dosing and Clinical Considerations
Knowing the dosing framework helps patients have informed conversations with their prescribers about what to expect.
Standard Dosing
The FDA-approved labeling for vardenafil recommends a starting dose of 10 mg taken approximately 60 minutes before sexual activity, with a maximum of one dose per 24 hours [5]. The dose may be increased to 20 mg or decreased to 5 mg based on efficacy and side effects. Food does not significantly affect absorption, unlike sildenafil, which is delayed by high-fat meals.
Efficacy Data
The Porst et al. 2003 trial randomized 580 men with ED to vardenafil 5 mg, 10 mg, 20 mg, or placebo. At 12 weeks, the 20 mg group reported successful penetration in 80% of attempts versus 52% for placebo. The IIEF erectile function domain score improved by 7.4 points with 20 mg versus 1.7 points with placebo (P<0.001) [3]. A meta-analysis by Yuan et al. (2013) pooling 8,554 patients across 38 trials confirmed vardenafil's efficacy across ED severity levels and etiologies, including diabetes-related ED [6].
Dose Adjustments
Patients taking moderate CYP3A4 inhibitors (erythromycin, fluconazole) should start at 5 mg. Strong CYP3A4 inhibitors (ketoconazole, ritonavir) require a maximum dose of 2.5 mg. Alpha-blocker co-administration (tamsulosin, doxazosin) requires stable alpha-blocker dosing and a vardenafil starting dose of 5 mg, separated by at least 6 hours [5].
Side Effect Profile
The most common adverse effects in clinical trials were headache (15%), flushing (11%), rhinitis (9%), and dyspepsia (4%). Vardenafil has a small effect on the QTc interval; the FDA label notes a mean QTc increase of 8 ms at 10 mg and advises caution in patients with congenital QT prolongation or those taking Class IA or III antiarrhythmics [5].
Timeline: From Consultation to Medication in Hand
Patients in Oklahoma can realistically go from initial consultation to having vardenafil in hand within 1 to 3 days using telehealth, or the same day with an in-person visit if the pharmacy has stock.
Telehealth Timeline
- Day 1: Complete intake questionnaire and synchronous video visit (15 to 20 minutes). Prescription sent to pharmacy.
- Day 1 to 2: Pharmacy fills prescription. If labs are needed, the prescriber may require results before finalizing. Labs drawn at a local facility return in 1 to 2 business days.
- Day 2 to 3: Pick up at pharmacy or receive via mail order.
In-Person Timeline
- Day 1: Visit a primary care physician, urologist, or men's health clinic. If no contraindications are identified, the prescription is sent during the visit. Pick up at a nearby pharmacy the same day.
For patients using 503A compounding pharmacies, add 2 to 5 business days for compounding and shipping if the pharmacy is not local.
Oklahoma-Specific Resources
Oklahoma residents have several additional access points worth knowing. The Oklahoma State Board of Pharmacy maintains a public lookup tool for verifying pharmacy licensure, including compounding pharmacies. The Oklahoma Medical Board's license verification portal confirms whether a telehealth prescriber holds an active Oklahoma license. Patients experiencing prior authorization denials can file complaints with the Oklahoma Insurance Department, which oversees external review processes for commercial plans [7].
Generic vardenafil 10 mg, one tablet taken 30 to 60 minutes before sexual activity, with no more than one dose in 24 hours and a cardiovascular reassessment at 6 to 12 months per the AUA guideline on ED management [2].
Frequently asked questions
›How do I get a vardenafil (Levitra/Staxyn) prescription in Oklahoma?
›What labs are needed before vardenafil in Oklahoma?
›Are there telehealth providers in Oklahoma prescribing vardenafil?
›How long until I receive vardenafil in Oklahoma?
›Can I transfer a vardenafil prescription to Oklahoma?
›Are 503A pharmacies in Oklahoma licensed to ship vardenafil?
›Who can prescribe vardenafil in Oklahoma: MD vs NP vs PA?
›What documentation does prior authorization require in Oklahoma?
›Does Oklahoma Medicaid cover vardenafil?
›What is the cost of generic vardenafil in Oklahoma without insurance?
References
- Kloner RA, Hutter AM, Emmick JT, et al. Time course of the interaction between tadalafil and nitrates. J Am Coll Cardiol. 2003;42(10):1855-1860. https://pubmed.ncbi.nlm.nih.gov/14642699/
- Burnett AL, Nehra A, Breau RH, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/29746858/
- Porst H, Rosen R, Padma-Nathan H, et al. The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction. Int J Impot Res. 2001;13(4):192-199. https://pubmed.ncbi.nlm.nih.gov/12834456/
- Baser O, Karaca Z, Du J. Coverage and cost analysis of PDE5 inhibitors in US commercial health plans. J Sex Med. 2019;16(2):253-260. https://pubmed.ncbi.nlm.nih.gov/30573365/
- Vardenafil (Levitra) prescribing information. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021400s018lbl.pdf
- Yuan J, Zhang R, Yang Z, et al. Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis. Eur Urol. 2013;63(5):902-912. https://pubmed.ncbi.nlm.nih.gov/23651423/
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/